Drugs launching into crowded market baskets require pricing strategies that are customized for premium tolerability within a certain...

Bottom Line? Overall IHS access control and opportunity is more driven by site of care and less contingent on payer. Indian Health...

When speaking about the healthcare system under the Department of Defense (DOD), many individuals erroneously use the terms Defense...

Managed by the Defense Health Agency (DHA), TRICARE is the health care program that provides comprehensive health care coverage to its...

As a widely respected pharmaceutical industry publication, Life Science Leader provides an invaluable forum for industry dialogue, and...

Signed into law in August 2022 by President Biden, the Inflation Reduction Act (IRA) is considered a marked shift in how prescription...

1. Using a commercial market value proposition The Federal market prioritizes cost-effectiveness and a manufacturer’s (or...

Establishing and maintaining a Federal Supply Schedule (FSS) contract can be a daunting and resource-draining task if the Federal market...

Established in 1954, the Indian Health Services (IHS), an agency within the Department of Health and Human Services (DHHS), is...

One component of negotiating a product’s price on the Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) price negotiation...

The Veterans Healthcare Administration (VHA) presents a unique market opportunity for pharmaceutical companies and medical device...

Medical devices are a vital component of healthcare in the Department of Veterans Affairs (VA) offering veterans improved diagnosis and...